top of page
Cells of glandular epithelium, microscopic photo of permanent preparation.jpg

impairED GALT

GALT stands for gut-associated lymphoid tissue, which is the immune system of your digestive tract, and it makes up about 70% of your body’s total immune defences. Its role is to protect you from pathogens, whilst not overreacting to harmless matter, like food or beneficial bacteria.

 

Within the GALT are special ‘stations’ such as Peyer’s patches, the lamina propria, and mesenteric lymph nodes. These are filled with immune cells like T cells, B cells, macrophages, and dendritic cells.

 

The immune process in the GALT works in a series of steps. First, M cells act like guards, collecting samples of food particles, bacteria, and other substances in the gut. They hand these samples to dendritic cells. Dendritic cells then decide if the sample is dangerous or not. To do this, they travel to nearby lymph nodes and show the sample to T and B cells, teaching them whether they should respond. If activated, these cells move to the lamina propria, just under the surface of the intestine.

 

Activated B cells then turn into plasma cells and make the gut’s main antibody called secretory IgA (sIgA). This antibody works within the mucus that coats the gut lining as a major line of defence. Here it blocks pathogens from adherence to the lining, neutralises toxins, and helps control the balance of micropopulations. 

 

An impaired GALT system refers to an inefficiency in digestive defences or ability to protect and balance. This impairment can result from: 

 

  • Faulty T cells

  • B cells that don’t mature properly

  • Missing M cells

  • Low levels of secretory IgA. 

 

When this occurs, chronic or repeated digestive infections are a much higher probability, alongside an imbalance in micropopulations and poor control over inflammatory responses. The result of which is the occurrence of digestive complaints, digestive disorders and a host of systemic outcomes that correlate with in imbalance of beneficial vs pathogenic / virulent organisms [1][2][3][4][5]

Signs & Symptoms

Chronic Digestive Disturbances

 

Chronic digestive disturbances are closely associated with dysfunction of the gut-associated lymphoid tissue (GALT), which serves as a primary immune aid within the intestinal lining. When GALT activity is compromised, the gut’s ability to regulate necessary immune responses and maintain mucosal integrity declines. Over time, this dysfunction leads to microbial imbalance and persistent inflammation, heightening the susceptibility to infections and prolonging the resolution of pre-existing infections. [6][7][8][9]

 

The following conditions are closely linked to GALT impairments, with both the severity and persistence of the condition reflecting the likelihood of GALT support required. 

 

  • Small Intestinal Bacterial Overgrowth

  • Candidiasis 

  • Helminth Infection - Worms

  • Protozoal Infection - Parasites 

  • Dysbiosis 

  • Biofilms 

  • Functional Dyspepsia - H.Pylori Positive 

  • Inflammatory Bowel Diseases

  • Recurrent Diarrhea

Causes

Chronic Stress [ SNS Hyperactivity ] + High Cortisol [ Hypercortisolism ]

 

Various studies indicate that although short-term stress may increase sIgA levels, chronic or prolonged stress leads to a decrease in sIgA production. This suppression is associated with persistent activation of the hypothalamic-pituitary-adrenal (HPA) axis, resulting in elevated cortisol levels. High cortisol can inhibit the secretion and transport of sIgA across mucosal surfaces, weakening the first line of the GI immune defense. [14][15].

 

Another study demonstrated that chronic stress caused sIGA declines whilst experiencing the stress, but also that the sIGA levels remained low for 6 days after the stress was alleviated. [16] 

 

Chronic Infections 

 

  • SIBO

  • Candidasis

  • Dysbiosis

  • Helminth Infection

  • Protozoa Infection

 

Chronic gastrointestinal infections create a state of persistent immune system activation, which has a direct impact on levels of secretory IgA (sIgA), the gut’s frontline antibody for mucosal defense. 

 

Under normal conditions, sIgA forms a protective coating along the intestinal lining, preventing pathogens from attaching, neutralizing toxins, and supporting a healthy microbial balance.

When infections become long-standing, however, several interconnected mechanisms reduce the body’s ability to maintain adequate sIgA, including:

 

Resource diversion: Continuous inflammation forces the immune system to prioritize pro-inflammatory pathways, leaving fewer resources available for the specialized process of IgA production.
 

Impaired B-cell signaling: Normally, B cells undergo ‘class switching’ to become IgA-producing plasma cells. Chronic immune stress disrupts this signaling, limiting the conversion to IgA-producing cells.
 

Excessive demand: Persistent infections create a constant need for sIgA. Over time, this demand outpaces the body’s ability to produce and secrete sufficient antibody levels.
 

Cytokine imbalance: Pro-inflammatory cytokines, such as TNF-α and IL-6  dominate in chronic infections. These suppress the anti-inflammatory cytokines like IL-10, that are essential for promoting IgA class switching.
 

The combined effect is a gradual depletion of sIgA, leaving the mucosal barrier weakened. This increases susceptibility to further microbial overgrowth, recurrent infections, dysbiosis, and ongoing cycles of inflammation. Over time, this vicious cycle contributes not only to local gut dysfunction but also to chronic states of GI dysfunction or disease. [17][18][19][20]

 

Low Mucus Production 

 

The mucus gel layer covering the gastrointestinal tract is an important component of the gut-associated lymphoid tissue (GALT) as it is home to sIGA, as well as home to the bacteria necessary to produce beneficial short-chain fatty acids (SCFAs) through fermentation.

 

Subsequently poor mucus production or mucus layer degradation limits housing availability. The resulting reduction of SCFAs causes GI immune impairments and dysfunctions because SCFAs initiate signaling pathways that influence immune cell function, enhance mucosal immunity and support the development of Treg cells. The reduction of sIGA limits the guts main antibody from performing its work to clear pathogenic organisms. [10][11][12][13]

 

Antibiotics

 

Antibiotic treatments can affect the development of important immune structures such as the Peyer’s patches. These patches are crucial for the immune system to function properly. Antibiotics can also reduce the number of immune cells in the gut, which leads to a long-term decrease in the formation of germinal centers, which are areas where immune cells are activated. Antibiotics have also been associated with a reduction in the production of IgA. [21][22]

 

High Fat, Low Fibre Diets

 

Clinical studies have demonstrated that GALT is sensitive to the changes in the dietary composition. With high fat contributing to the destruction of T cells in the GALT. Whereas high fibre has been associated with increased T-cell immune responses and macrophage activity in the gut.It also promotes a greater number of M cells. [23][24]

 

Nutrient Deficiency 

 

Specific vitamins and amino acids play integral roles in the GALT. Deficiencies in the following have a negative impact on the GALT system.

 

  • Vitamin A

  • Vitamin D

  • Threonine

References

 

[1] https://pmc.ncbi.nlm.nih.gov/articles/PMC11172644/

[2].https://vivo.colostate.edu/hbooks/pathphys/digestion/basics/gi_immune.html

[3].https://www.tandfonline.com/doi/full/10.1080/00365521.2017.1349173

[4].https://www.sciencedirect.com/science/article/abs/pii/S1357303924000215

[5] https://pmc.ncbi.nlm.nih.gov/articles/PMC11172644/

[6] https://pmc.ncbi.nlm.nih.gov/articles/PMC6537874/

[7] https://pmc.ncbi.nlm.nih.gov/articles/PMC10064982/

[8] https://pubmed.ncbi.nlm.nih.gov/5056860/

[9] https://pmc.ncbi.nlm.nih.gov/articles/PMC10506939/

[10] https://www.thelancet.com/journals/langas/article/PIIS2468-1253(21)00431-3/abstract?utm

[11] https://www.nature.com/articles/s41423-023-00987-1.pdf

[12].https://www.biomedica.com.au/media/contentmanager/content/Gastrointestinal_Tissue_Integrity.pdf

[13] https://www.cghjournal.org/article/S1542-3565(24)00902-9/abstract

[14] https://pmc.ncbi.nlm.nih.gov/articles/PMC4490024/

[15] https://pubmed.ncbi.nlm.nih.gov/10858568/

[16] https://pubmed.ncbi.nlm.nih.gov/10858568/

[17] https://www.ncbi.nlm.nih.gov/books/NBK551516/

[18] https://pubmed.ncbi.nlm.nih.gov/24157629/

[19] https://www.ncbi.nlm.nih.gov/books/NBK538205/

[20] https://pmc.ncbi.nlm.nih.gov/articles/PMC7731431/

[21] https://pubmed.ncbi.nlm.nih.gov/30462346/

[22].https://www.sciencedirect.com/science/article/pii/S2589004223008878

[23].https://www.sciencedirect.com/science/article/abs/pii/S0531556521001868#:~:text=High%2Dfat%20diet%20(HFD),cell%20senescence%20in%20the%20GAL

[24] https://www.nature.com/articles/s41598-018-32484-1

bottom of page